Literature DB >> 26103530

Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes.

Fabiana As Brandão1, Lorena S Derengowski1, Patrícia Albuquerque2,3, André M Nicola3,4, Ildinete Silva-Pereira1, Marcio J Poças-Fonseca5.   

Abstract

Cryptococcus neoformans undergoes phenotypical changes during host infection in order to promote persistence and survival. Studies have demonstrated that such adaptations require alterations in gene transcription networks by distinct mechanisms. Drugs such as the histone deacetylases inhibitors (HDACi) Sodium Butyrate (NaBut) and Trichostatin A (TSA) can alter the chromatin conformation and have been used to modulate epigenetic states in the treatment of diseases such as cancer. In this work, we have studied the effect of NaBut and TSA on the expression of C. neoformans major virulence phenotypes and on the survival rate of an animal model infected with drugs-treated yeasts. Both drugs affected fungal growth at 37°C more intensely than at 30°C; nonetheless, drugs did not affect cell viability at the concentrations we studied. HDACi also provoked the reduction of the fungal capsule expansion. Phospholipases enzyme activity decreased; mating process and melanin synthesis were also affected by both inhibitors. NaBut led to an increase in the population of cells in G2/M. Treated yeast cells, which were washed in order to remove the drugs from the culture medium prior to the inoculation in the Galleria mellonela infection model, did not cause significant difference at the host survival curve when compared to non-treated cells. Overall, NaBut effects on the impairment of C. neoformans main virulence factors were more intense and stable than the TSA effects.

Entities:  

Keywords:  Cryptococcus neoformans; Trichostatin A; chromatin structure; histone deacetylases inhibitors; sodium butyrate; virulence factors

Mesh:

Substances:

Year:  2015        PMID: 26103530      PMCID: PMC4720250          DOI: 10.1080/21505594.2015.1038014

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  70 in total

1.  Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection.

Authors:  Kirsten Nielsen; Gary M Cox; Anastasia P Litvintseva; Eleftherios Mylonakis; Stephanie D Malliaris; Daniel K Benjamin; Steven S Giles; Thomas G Mitchell; Arturo Casadevall; John R Perfect; Joseph Heitman
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Butyrate induces apoptosis in murine macrophages via caspase-3, but independent of autocrine synthesis of tumor necrosis factor and nitric oxide.

Authors:  M G Ramos; F L A Rabelo; T Duarte; R T Gazzinelli; J I Alvarez-Leite
Journal:  Braz J Med Biol Res       Date:  2002-02       Impact factor: 2.590

3.  The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.

Authors:  Brian F Hinnebusch; Shufen Meng; James T Wu; Sonia Y Archer; Richard A Hodin
Journal:  J Nutr       Date:  2002-05       Impact factor: 4.798

4.  Sodium butyrate induces G2 arrest in the human breast cancer cells MDA-MB-231 and renders them competent for DNA rereplication.

Authors:  F Lallemand; D Courilleau; C Buquet-Fagot; A Atfi; M N Montagne; J Mester
Journal:  Exp Cell Res       Date:  1999-03-15       Impact factor: 3.905

5.  Cryptococcus neoformans. II. Phagocytosis by human leukocytes.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

6.  Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans.

Authors:  Oliver W Liu; Cheryl D Chun; Eric D Chow; Changbin Chen; Hiten D Madhani; Suzanne M Noble
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

7.  Genetic association of mating types and virulence in Cryptococcus neoformans.

Authors:  K J Kwon-Chung; J C Edman; B L Wickes
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

8.  Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants.

Authors:  Y Wang; A Casadevall
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

9.  Toward an integrated model of capsule regulation in Cryptococcus neoformans.

Authors:  Brian C Haynes; Michael L Skowyra; Sarah J Spencer; Stacey R Gish; Matthew Williams; Elizabeth P Held; Michael R Brent; Tamara L Doering
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

10.  Quorum sensing-mediated, cell density-dependent regulation of growth and virulence in Cryptococcus neoformans.

Authors:  Patrícia Albuquerque; André M Nicola; Edward Nieves; Hugo Costa Paes; Peter R Williamson; Ildinete Silva-Pereira; Arturo Casadevall
Journal:  MBio       Date:  2013-12-31       Impact factor: 7.867

View more
  19 in total

1.  Histone deacetylases: Targets for antifungal drug development.

Authors:  Livia Kmetzsch
Journal:  Virulence       Date:  2015-07-07       Impact factor: 5.882

Review 2.  Epigenetic mechanisms of drug resistance in fungi.

Authors:  Zanetta Chang; Vikas Yadav; Soo Chan Lee; Joseph Heitman
Journal:  Fungal Genet Biol       Date:  2019-07-17       Impact factor: 3.495

3.  Different histone deacetylase inhibitors reduce growth, virulence as well as changes in the morphology of the fungus Macrophomina phaseolina (Tassi) Goid.

Authors:  Víctor Hugo Ramos-García; Nubia Andrea Villota-Salazar; Juan Manuel González-Prieto; Diana V Cortés-Espinosa
Journal:  World J Microbiol Biotechnol       Date:  2022-02-28       Impact factor: 3.312

Review 4.  Post-Translational Modifications of Histones Are Versatile Regulators of Fungal Development and Secondary Metabolism.

Authors:  Aurelie Etier; Fabien Dumetz; Sylvain Chéreau; Nadia Ponts
Journal:  Toxins (Basel)       Date:  2022-04-29       Impact factor: 5.075

Review 5.  Regulatory Roles of Histone Modifications in Filamentous Fungal Pathogens.

Authors:  Yiling Lai; Lili Wang; Weilu Zheng; Sibao Wang
Journal:  J Fungi (Basel)       Date:  2022-05-25

Review 6.  Cryptococcal therapies and drug targets: the old, the new and the promising.

Authors:  Carolina Coelho; Arturo Casadevall
Journal:  Cell Microbiol       Date:  2016-04-08       Impact factor: 3.715

Review 7.  Lysine acetylation as drug target in fungi: an underexplored potential in Aspergillus spp.

Authors:  Natália Sayuri Wassano; Ariely Barbosa Leite; Franqueline Reichert-Lima; Angelica Zaninelli Schreiber; Nilmar S Moretti; André Damasio
Journal:  Braz J Microbiol       Date:  2020-03-13       Impact factor: 2.476

Review 8.  Structure-guided approaches to targeting stress responses in human fungal pathogens.

Authors:  Emmanuelle V LeBlanc; Elizabeth J Polvi; Amanda O Veri; Gilbert G Privé; Leah E Cowen
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

9.  Microevolution of Serial Clinical Isolates of Cryptococcus neoformans var. grubii and C. gattii.

Authors:  Yuan Chen; Rhys A Farrer; Charles Giamberardino; Sharadha Sakthikumar; Alexander Jones; Timothy Yang; Jennifer L Tenor; Omar Wagih; Marelize Van Wyk; Nelesh P Govender; Thomas G Mitchell; Anastasia P Litvintseva; Christina A Cuomo; John R Perfect
Journal:  mBio       Date:  2017-03-07       Impact factor: 7.867

10.  HDAC genes play distinct and redundant roles in Cryptococcus neoformans virulence.

Authors:  Fabiana Brandão; Shannon K Esher; Kyla S Ost; Kaila Pianalto; Connie B Nichols; Larissa Fernandes; Anamélia L Bocca; Marcio José Poças-Fonseca; J Andrew Alspaugh
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.